BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4147058)

  • 1. The role of norfenfluramine in fenfluramine-induced mydriasis.
    Kramer R; Rubicek M; Turner P
    J Pharm Pharmacol; 1973 Jul; 25(7):575-6. PubMed ID: 4147058
    [No Abstract]   [Full Text] [Related]  

  • 2. Guanethidine (Ismelin) as an adjuvant in pharmacological mydriasis.
    JabloĊ„ski J
    Ophthalmologica; 1974; 168(1):27-38. PubMed ID: 4842826
    [No Abstract]   [Full Text] [Related]  

  • 3. Sympathetic stimulators and blockers.
    Gillum WN
    Ophthalmic Semin; 1977; 2(3):283-326. PubMed ID: 144884
    [No Abstract]   [Full Text] [Related]  

  • 4. Interactions of iprindole with fenfluramine metabolism in rat brain and liver.
    Hegadoren KM; Baker GB; Coutts RT; Dewhurst WG
    J Psychiatry Neurosci; 1991 Mar; 16(1):5-11. PubMed ID: 2049371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fenfluramine metabolite (+)-norfenfluramine is vasoactive.
    Ni W; Li MW; Thakali K; Fink GD; Watts SW
    J Pharmacol Exp Ther; 2004 May; 309(2):845-52. PubMed ID: 14752059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of thymoxamine on changes in pupil diameter and accommodation produced by homatropine and ephedrine.
    Small S; Stewart-Jones JH
    Br J Ophthalmol; 1976 Feb; 60(2):132-4. PubMed ID: 131576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenfluramine and norfenfluramine levels in brain microdialysate, brain tissue and plasma of rats administered doses of d-fenfluramine known to deplete 5-hydroxytryptamine levels in brain.
    Clausing P; Newport GD; Bowyer JF
    J Pharmacol Exp Ther; 1998 Feb; 284(2):618-24. PubMed ID: 9454806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin response to fenfluramine is independent of serotonin release.
    McCann UD; Hatzidimitriou G; Ricaurte GA
    Eur J Pharmacol; 1996 Sep; 312(2):R1-2. PubMed ID: 8894606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymoxamine versus pilocarpine in the reversal of phenylephrine-induced mydriasis.
    Saheb NE; Lorenzetti D; East D; Salpeter-Carlton S
    Can J Ophthalmol; 1982 Dec; 17(6):266-7. PubMed ID: 6219733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ephedrine mydriasis in hypertension and the response to treatment.
    Sneddon JM; Turner P
    Clin Pharmacol Ther; 1969; 10(1):64-71. PubMed ID: 5763657
    [No Abstract]   [Full Text] [Related]  

  • 11. Thymoxamine reverses phenylephrine-induced mydriasis.
    Relf SJ; Gharagozloo NZ; Skuta GL; Alward WL; Anderson DR; Brubaker RF
    Am J Ophthalmol; 1988 Sep; 106(3):251-5. PubMed ID: 2971321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the CNS effects of fenfluramine, 780SE and norfenfluramine on animals and man.
    Reuter CJ
    Postgrad Med J; 1975; 51 Suppl 1():18-27. PubMed ID: 768966
    [No Abstract]   [Full Text] [Related]  

  • 13. Different effects of fenfluramine isomers and metabolites on extracellular 5-HIAA in nucleus accumbens and hippocampus of freely moving rats.
    De Simoni MG; Juraszczyk Z; Fodritto F; De Luigi A; Garattini S
    Eur J Pharmacol; 1988 Aug; 153(2-3):295-9. PubMed ID: 2460361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of fenfluramine to norfenfluramine in guinea-pigs.
    Fuller RW; Snoddy HD; Perry KW
    J Pharm Pharmacol; 1988 Jun; 40(6):439-41. PubMed ID: 2458444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is receptor activation involved in the mechanism by which (+)-fenfluramine and (+)-norfenfluramine deplete 5-hydroxytryptamine in the rat brain?
    Invernizzi R; Kmieciak-Kolada K; Samanin R
    Br J Pharmacol; 1982 Mar; 75(3):525-30. PubMed ID: 6175368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between d-fenfluramine and d-norfenfluramine in serotonin presynaptic mechanisms.
    Borroni E; Ceci A; Garattini S; Mennini T
    J Neurochem; 1983 Mar; 40(3):891-3. PubMed ID: 6827286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenfluramine and 5-hydroxytryptamine?. Part 1: Is fenfluramine or norfenfluramine involved in the decrease of brain 5-hydroxytryptamine.
    Duhault J; Malen C; Boulanger M; Voisin C; Beregi L; Schmitt H
    Arzneimittelforschung; 1975 Nov; 25(11):1755-8. PubMed ID: 1243082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of d-norfenfluramine in the indole-depleting effect of d-fenfluramine in the rat.
    Caccia S; Anelli M; Ferrarese A; Fracasso C; Garattini S
    Eur J Pharmacol; 1993 Mar; 233(1):71-7. PubMed ID: 7682511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.
    Rothman RB; Baumann MH; Savage JE; Rauser L; McBride A; Hufeisen SJ; Roth BL
    Circulation; 2000 Dec; 102(23):2836-41. PubMed ID: 11104741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of fenfluramine isomers in the rat.
    Caccia S; Dagnino G; Garattini S; Guiso G; Madonna R; Zanini MG
    Eur J Drug Metab Pharmacokinet; 1981; 6(4):297-301. PubMed ID: 7333330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.